DANIEL PLANT: Open Payments
NPI 1710746797 · LOGAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$223 in 5 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $160 · 2025 $223
Food & beverage: $163Education: $60
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $127 |
| Ardelyx, Inc. | 1 | $50 |
| Gilead Sciences, Inc. | 1 | $37 |
| Janssen Pharmaceuticals, Inc | 1 | $9 |
Products named: TREMFYA, IBSRELA, Livdelzi.
Industry payments across UT — which companies pay providers there.
